Compare STIM & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STIM | EPM |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 137.2M |
| IPO Year | 2018 | 1996 |
| Metric | STIM | EPM |
|---|---|---|
| Price | $3.16 | $3.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.00 | ★ $4.83 |
| AVG Volume (30 Days) | ★ 3.1M | 278.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 10.08% |
| EPS Growth | ★ 57.25 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $52,776,000.00 | $43,229,621.00 |
| Revenue This Year | $11.10 | N/A |
| Revenue Next Year | $11.92 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $3.19 |
| 52 Week High | $3.71 | $5.70 |
| Indicator | STIM | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 68.59 | 54.70 |
| Support Level | $1.16 | $3.48 |
| Resistance Level | N/A | $4.10 |
| Average True Range (ATR) | 0.30 | 0.09 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 79.06 | 82.95 |
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.